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E-mail: dctolis@gmail.comIntroductionErysipelothrix rhusiopathiae is a Gram-positive bacterium that is
mainly responsible for skin infection, mostly erysipeloid, in
humans. The infection derives from direct contact with infected
animals, usually domestic swine, and their products or wastes.
We report a rare case of a 30-year-old woman with tenosyn-
ovitis of her right middle ﬁnger.Case presentationA 30-year-old Nigerian woman was admitted to our depart-
ment with a medical history of swollen and painful middle ﬁnger
of her right hand, which had progressively worsened over the
last 3 days. No fever other constitutional symptoms were
detected. She reported a recent penetrating trauma by a ﬁsh
bone. No systemic diseases were documented.
Physical examination revealed edema, pain at rest, warmth
and a reddish middle ﬁnger with extension to the volar andw Microbe and New Infect 2015; 8: 128–130
w Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
is is an open access article under the CC BY-NC-ND license (http://creativecommons.org/lice
p://dx.doi.org/10.1016/j.nmni.2015.10.007dorsal area of her hand. Skin decolourisation was not diagnostic
for erysipeloid at that time. Although the range of motion of the
interphalangeal and metacarpophalangeal joints was completely
restricted, no vascular impairment was documented. Her pe-
ripheral white blood cell count was 13 300/μL (71% neutro-
phils, 17.8% lymphocytes, 10.1% monocytes), and C-reactive
protein was 0.33 mg/dL (normal range, 0.5–0.7 mg/dL). All
other blood tests had results within normal ranges. The diag-
nosis was tenosynovitis of both the ﬂexor and extensor
mechanisms of the middle digit. Surgical decompression and
debridement comprised the treatment of choice.
Under brachial block, a straight incision was performed
dorsally, while a Bruner incision was preferred for the palmar
area. During dissection, a serous ﬂuid, but no pus, was collected
and sent for culture. Copious irrigation with saline and
hydrogen peroxide was performed during surgical exploration.
Empirical intravenous antibiotic therapy was initiated immedi-
ately after surgery, including cefuroxime (750 mg/8 hours),
ciproﬂoxacin (500 mg/12 hours) and clindamycin (600 mg/8
hours).
Fluid culture revealed Enterococcus faecalis in the ﬁrst 24
hours, while a Gram-positive bacterium grew after 48 hours
(Fig. 1), which proved to be Erysipelothrix rhusiopathiae. The
pathogen was sensitive to penicillin, ampicillin, imipenem,
cefuroxime, ceftriaxone, clindamycin and linezolid, while being
resistant to vancomycin, teicoplanin, trimethoprim–sulfameth-
oxazole and tetracycline. The patient continued antibioticEuropean Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
FIG. 1. Gram’s stain, high power showing gram-positive ﬁlaments
typical of Erysipelothrix rhusiopathiae.
FIG. 3. Dorsal view of middle ﬁnger. Flexion was restored to near-
normal function 3 months after surgery.
NMNI Tolis et al. Tenosynovitis of a digit 129therapy for 2 weeks, followed by 2 weeks of oral antibiotics
after being discharged from hospital.
Within the 3 months’ follow-up, the inﬂammation markers
were within the normal range, and the patient regained mobility
in her digit after an intensive physiotherapy programme (Figs. 2
and 3). No signs of recurrence of the disease or of osteomy-
elitis were detected during follow-up.DiscussionErysipelothrix rhusiopathiae was ﬁrst isolated in 1876 by Koch [1]
in a mouse. Not until 1884 did Rosenbach establish it as a
human pathogen. It is considered to be a Gram-positive,FIG. 2. Palmar view of middle ﬁnger. No signs of infection are
observed. Superﬁcial pulp skin necrosis and slight stiffness of proximal
interphalangeal joint can be seen.
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This is an open access articapsulated saprophyte, with worldwide spread and affecting
mostly domestic and wild animals. Erysipelothrix [2] is referred
to as an occupational bacteria because its contact with infected
animals or their waste causes a variety of clinical syndromes.
Sheep, chickens, rodents, shellﬁsh, turkeys and ducks are usual
hosts, but domestic swine is the dominant reservoir for the
microorganism. It is not only professional workers [3], such as
ﬁshermen, farmers or butchers, who are considered to be at
high risk when in close contact with infected animals. Infection
can also be accidental [4], the result of its ability to remain
viable in water and animal products, such as ham, or in ﬁsh for a
long period without forming spores [5]. Human-to-human
infection has not been reported.
Erysipeloid is the most common form of infection in
humans. It is a mild, cutaneous infection, lasting between 2 and
4 weeks and usually self-limiting. Lesions are conﬁned to ﬁn-
gers and hands, which are being swollen and painful, with
spreading at the periphery and decolourization of the central
area [6]. Systemic effects are rare, although lymphadenopathy
and lymphangiitis are detected in one third of patients [7].
Adjacent arthritis may occur. The diffuse cutaneous form is
even rarer, combined with systemic symptoms such as fever,
severe headache and even polyarthritis. Recurrence is more
often compared to erysipeloid. The most severe form of
infection, though the rarest, due to Erysipelothrix is septicaemia,
which is almost always related to endocarditis. The aortic valve
[8] is mostly affected, with 35% of patients requiring replace-
ment. Mortality is up to 40%, regardless of antibiotic treat-
ment. Risk factors for bactaeremia include diabetes,
immunosuppression, alcoholism [9] or renal failure as well as
infancy.
Although rarely mentioned in the orthopaedic literature,
reports from the last decade show that Erysipelothrixof European Society of Clinical Microbiology and Infectious Diseases, NMNI, 8, 128–130
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tive arthritis [10], osteomyelitis [10], prosthetic infection [11]
and spondylitis [12]. It has also caused septic arthritis after
arthroscopic reconstruction of an anterior cruciate ligament
[13]. Therefore, tenosynovitis is a rare form of erysipeloid.
Although it is a known occupational pathogen, its infections
are often misdiagnosed. In cases of erysipeloid, biopsy samples
should be taken of the entire thickness of the dermis, as the
bacterium lies in the deeper layers of the skin. When sepsis or
endocarditis is diagnosed, a standard blood culture should be
performed. Specimens must be put in an infusion broth of 1%
glucose at room temperature until reaching the laboratory.
Identiﬁcation should be based on Gram stain, morphology,
motility, and hemolytic and biochemical properties, especially
production of H2S [2]. Generally Erysipelothrix should not be
confused with Actinomyces, Lactobacillus, Streptococcus, Listeria
monocytogenes or Enterococcus spp.
Penicillin, cephalosporins, ﬂuoroquinolones and lincosamides
are the main antibiotic categories used for treatment against
infections due to Erysipelothrix. The bacterium is highly resistant
to aminoglycosides [2], vancomycin, sulfonamides, strepto-
mycin and trimethoprim–sulfamethoxazole. Resistance to
vancomycin is endogenous as a result of the vanC gene. Sus-
ceptibility varies amongst chloramphenicol, tetracyclines and
erythromycin. Penicillin G [14] is considered the drug of choice,
in doses varying from 12 × 106 to 20 × 106 U/day. Duration of
treatment period depends on whether or not the infection is
systemic. In cases of bactaeremia or endocarditis, 4 to 6 weeks
of continuous antibiotic therapy is considered an effective
treatment period. In complicated cases [15] or in cases of im-
mediate recurrence of the disease, antibiotics can be adminis-
trated for up to 16 weeks.
Orthopaedic surgeons should be aware of infections due to
Erysipelothrix rhusiopathiae, bearing in mind the close correla-
tion between certain professions and animals, domestic or
wild. Systemic or not, such infections must be identiﬁed
immediately in order to prevent severe complications such as
endocarditis. Prophylactic measures can reduce occupational
exposure and minimize the possible transmission of the
pathogen to humans.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
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